2027 ICD-10-CM Diagnosis Code F16.24Hallucinogen dependence with hallucinogen-induced mood disorder
ICD-10-CM Codes›F01–F99›F10-F19›F16
- Billable — Valid for Submission
- Risk Adjusts — HCC 137
- Chronic Condition
F16.24 is a billable ICD-10-CM diagnosis code for hallucinogen dependence with hallucinogen-induced mood disorder. It is valid on HIPAA claims for fiscal year 2027 (October 1, 2026 through September 30, 2027) and groups to MS-DRG 894 through 897. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Hallucinogen-related disorders.
For Medicare Advantage risk adjustment, F16.24 maps to CMS-HCC Category 137 (Drug Use Disorder, Moderate/Severe, or Drug Use with Non-Psychotic Complications) under the V28 model, adding a risk factor of about 0.424 for a community, non-dual, aged beneficiary in payment year 2027.
Code Identity
Code Classification
Medicare Risk Adjustment (HCC)Billing
F16.24 maps to a payment category in the CMS-HCC model used to risk-adjust Medicare Advantage payments. Weights are the published community factors for payment year 2027.
Source: CMS Payment Year 2027 risk adjustment mappings and model software. Weights are relative factors, not dollar amounts; a beneficiary's total RAF also includes demographics and interactions. Browse all CMS-HCC categories.
Instructional NotesGuidance
Instructions from the official ICD-10-CM Tabular List that apply to F16.24: its own notes plus those printed at F16.2, F16, and Chapter 5. A note printed at a category, block or chapter applies to every code under it.
Includes
Further defines, or gives examples of, the content of the category.
- ecstasy
- PCP
- phencyclidine
- disorders of psychological development
Applicable To
Conditions this code is used for: synonyms of the title or, for "other specified" codes, the conditions assigned to it. The list is not exhaustive.
- Other hallucinogen use disorder, moderate, with other hallucinogen induced bipolar or related disorder
- Other hallucinogen use disorder, moderate, with other hallucinogen induced depressive disorder
- Other hallucinogen use disorder, severe, with other hallucinogen-induced bipolar or related disorder
- Other hallucinogen use disorder, severe, with other hallucinogen-induced depressive disorder
- Phencyclidine use disorder, moderate, with phencyclidine induced bipolar or related disorder
- Phencyclidine use disorder, moderate, with phencyclidine induced depressive disorder
- Phencyclidine use disorder, severe, with phencyclidine induced bipolar or related disorder
- Phencyclidine use disorder, severe, with phencyclidine-induced depressive disorder
Excludes1
Not coded here: the excluded code is never reported together with this one, unless the two conditions are unrelated.
Excludes2
Not included here: the excluded condition is not part of this code, but a patient may have both, so both codes may be reported.
Source: CMS ICD-10-CM Tabular List. How to read instructional notes.
Referenced in Other NotesGuidance
Instructional notes printed at other codes that name F16.24, its category, or a range that includes it.
Excludes1 2
These codes carry an Excludes1 note naming F16.24: they are not reported together with it, unless the two conditions are unrelated.
Index to Diseases and InjuriesGuidance
Alphabetical index entries that point to this code.
Disorder (of) See Also: Disease;
dependence F16.24
dependence F16.24
Clinical ClassificationClinical
AHRQ’s CCSR groups this code into broader clinical categories.
Clinical InformationClinical
Hallucinogen Dependence
a drug dependence for a hallucinogenic substance.
Patient EducationClinical
Drug Use and Addiction
Drugs are chemical substances that can change how your body and mind work. They include prescription medicines, over-the-counter medicines, alcohol, tobacco, and illegal drugs.
The full article covers:
- What are drugs?
- What is drug use?
- What is drug addiction?
- Does everyone who takes drugs become addicted?
- Who is at risk for drug addiction?
- What are the signs that someone has a drug problem?
- What are the treatments for drug addiction?
- Can drug use and addiction be prevented?
Read the full article at MedlinePlus
Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.
Convert F16.24 to ICD-9-CMHistory
The closest ICD-9-CM equivalents under the General Equivalence Mappings.
Code HistoryHistory
Questions About F16.24Overview
What is the ICD-10 code for hallucinogen dependence with hallucinogen-induced mood disorder?
The ICD-10-CM code for hallucinogen dependence with hallucinogen-induced mood disorder is F16.24 (sometimes written as F1624). It is billable on HIPAA-covered claims from October 1, 2026 through September 30, 2027.
Is F16.24 (Hallucinogen dependence) a billable code?
Yes. This is a billable ICD-10-CM code, specific enough to report hallucinogen dependence with hallucinogen-induced mood disorder on HIPAA-covered claims from October 1, 2026 through September 30, 2027.
What MS-DRG does F16.24 group to?
When hallucinogen dependence with hallucinogen-induced mood disorder is the principal diagnosis on an inpatient stay, it groups to MS-DRG 894, 897, 895, 896, with relative weights from 0.6272 to 1.6610 depending on complications. Higher weights mean higher Medicare reimbursement.
Can F16.24 be reported with a code from F16.1?
Not as a rule. The Excludes1 note at F16.2, which applies to F16.24, lists "hallucinogen abuse (F16.1-)". An Excludes1 note means the excluded code is never reported together with this one; the only exception is when the two conditions are unrelated to each other (Official Guidelines, Section I.A.12.a).
What is the ICD-9 equivalent of F16.24?
Under the General Equivalence Mappings, hallucinogen dependence with hallucinogen-induced mood disorder converts to ICD-9-CM 292.84 (drug-induced mood disord) and 304.50 (hallucinogen dep-unspec). The mapping is approximate, so confirm the match fits the documentation.
What HCC is F16.24?
F16.24 (hallucinogen dependence with hallucinogen-induced mood disorder) maps to CMS-HCC Category 137 (Drug Use Disorder, Moderate/Severe, or Drug Use with Non-Psychotic Complications), commonly written as HCC 137, in the CMS-HCC V28 model used for Medicare Advantage risk adjustment in payment year 2027. It mapped to HCC 55 under the retired V24 model. It also maps in the PACE (CMS-HCC V22), ESRD (V21), and ESRD (V24) models. It does not map to any RxHCC in the Part D prescription drug model.
Does F16.24 risk-adjust for Medicare Advantage payment?
Yes. When documented and reported on a Medicare Advantage encounter, F16.24 adds a risk adjustment factor of about 0.424 to the beneficiary's RAF score for a community, non-dual, aged enrollee (published V28 weights range from 0.297 to 0.502 depending on the payment segment). A more severe related category (HCC 135 and HCC 136) supersedes it when both are reported. See the full factor table on the HCC 137 category page.
